BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 20709140)

  • 1. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
    Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
    Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer.
    Brindley DN
    J Cell Biochem; 2004 Aug; 92(5):900-12. PubMed ID: 15258914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.
    van Meeteren LA; Ruurs P; Christodoulou E; Goding JW; Takakusa H; Kikuchi K; Perrakis A; Nagano T; Moolenaar WH
    J Biol Chem; 2005 Jun; 280(22):21155-61. PubMed ID: 15769751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.
    Brindley DN; Lin FT; Tigyi GJ
    Biochim Biophys Acta; 2013 Jan; 1831(1):74-85. PubMed ID: 22954454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Phosphate Phosphatases and Cancer.
    Tang X; Brindley DN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.
    Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN
    J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate.
    Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML
    Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
    Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
    Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autotaxin and lysophospholipids in rheumatoid arthritis.
    Bourgoin SG; Zhao C
    Curr Opin Investig Drugs; 2010 May; 11(5):515-26. PubMed ID: 20419597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
    Tang X; Benesch MGK; Brindley DN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-ordinate regulation of growth factor receptors and lipid phosphate phosphatase-1 controls cell activation by exogenous lysophosphatidate.
    Pilquil C; Ling ZC; Singh I; Buri K; Zhang QX; Brindley DN
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):825-30. PubMed ID: 11709082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids.
    Brindley DN; English D; Pilquil C; Buri K; Ling ZC
    Biochim Biophys Acta; 2002 May; 1582(1-3):33-44. PubMed ID: 12069808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid phosphate phosphatases and their roles in mammalian physiology and pathology.
    Tang X; Benesch MG; Brindley DN
    J Lipid Res; 2015 Nov; 56(11):2048-60. PubMed ID: 25814022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
    Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
    Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
    Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
    FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells.
    Zhang R; Wang J; Ma S; Huang Z; Zhang G
    BMC Cell Biol; 2011 Mar; 12():11. PubMed ID: 21406114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid phosphate phosphatases and signaling.
    Brindley DN; Pilquil C
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S225-30. PubMed ID: 19066402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest.
    Samadi N; Bekele RT; Goping IS; Schang LM; Brindley DN
    PLoS One; 2011; 6(5):e20608. PubMed ID: 21647386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
    van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH
    Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.